Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7857977 | ROCKWELL MEDICAL INC | Packaging of ferric pyrophosphate for dialysis |
Sep, 2027
(4 years from now) | |
US7816404 | ROCKWELL MEDICAL INC | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
Apr, 2029
(6 years from now) |
Market Authorisation Date: 25 April, 2016
Treatment: Method of iron administration to treat patients in need of iron replacement
Dosage: FOR SOLUTION;INTRAVENOUS
3
United States
2
Canada
1
Slovenia
1
Croatia
1
Japan
1
Portugal
1
Denmark
1
Cyprus
1
Austria
1
Spain
1
Poland
1
European Union
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US7816404 | ROCKWELL MEDICAL INC | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
Apr, 2029
(6 years from now) |
Market Authorisation Date: 27 March, 2020
Treatment: Method of iron administration to treat patients in need of iron replacement therapy
Dosage: SOLUTION;INTRAVENOUS
2
United States
1
Slovenia
1
Croatia
1
Japan
1
Portugal
1
Denmark
1
Cyprus
1
Austria
1
Canada
1
Spain
1
Poland
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic